This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The academic medical centers received three-star ratings in isolated coronaryarterybypassgrafting (CABG) and isolated mitral valve replacement and repair (MVRR) surgeries.
It uses a three-star scale (3=better than expected, 2=as expected, 1=worse than expected) to rate institutions across five common cardiovascular procedures: coronaryarterybypassgrafting (CABG); aortic valve replacement (AVR); AVR and CABG; mitral valve replacement/repair (MVRR); and MVRR and CABG.
This study is designed to evaluate the Corrie Hybrid CR, a technology‐based, multicomponent health equity‐focused intervention as an alternative to traditional in‐center CR among patients recovering from a cardiac event, surgery, or procedure compared with usual care alone.MethodsThe mTECH‐Rehab (Impact of a Mobile Technology Enabled Corrie CR Program) (..)
Fearon WF, Zimmermann FM, Ding VY, Takahashi K, Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronaryarterybypassgrafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial. We can’t force it to happen. Reference 1.Fearon
Outcomes: vascular access-to-balloon, door-to-balloon, and first medical contact-to-balloon times; death, reinfarction in 30days, Bleeding Academic Research Consortium 3 type, coronaryarterybypassgrafting referral, and left ventricular ejection fraction %. We searched PubMed, Embase, and Cochrane Central.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content